Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Muscarinic receptor subtypes as potential targets to modulate oligodendrocyte progenitor survival, proliferation, and differentiation.
Disseminated cryptococcosis in a patient with multiple sclerosis treated with fingolimod.
Oxidative stress in multiple sclerosis patients in clinical remission: Association with the expanded disability status scale.
Pitfalls of 3D FLAIR Brain Imaging: A Prospective Comparison with 2D FLAIR.
Care of patients with multiple sclerosis.
Moyamoya disease can masquerade as multiple sclerosis.
A facilitation and co-ordination therapy approach to the treatment of multiple sclerosis.
Sub-millimeter imaging of brain-free water for rapid volume assessment in atrophic brains.
Teriflunomide: A Review of Its Use in Relapsing Multiple Sclerosis.
Polyphenols: multipotent therapeutic agents in neurodegenerative diseases.
[Quality of life of patients receiving long-term treatment with first-line disease-modifying drugs: results of a Russian multicenter study using MusiQoL.]
Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurol
Neuromyelitis optica IgG does not alter aquaporin-4 water permeability, plasma membrane M1/M23 isoform content, or supramolecular assembly.
Comparative analysis of first-year fingolimod and natalizumab drug discontinuation among Swedish patients with multiple sclerosis.
Month of birth as a risk factor for multiple sclerosis: an update.
Fingolimod in the treatment algorithm of relapsing remitting multiple sclerosis: a statement of the Central and East European (CEE) MS Expert Group.
The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis.
Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors.
Increased determinism in brain electrical activity occurs in association with multiple sclerosis.
Relocation of p25¿/tubulin polymerization promoting protein from the nucleus to the perinuclear cytoplasm in the oligodendroglia of sporadic and COQ2 mutant multiple system atrophy.
Protein tyrosine phosphatase receptor type z negatively regulates oligodendrocyte differentiation and myelination.
Minocycline attenuates iron neurotoxicity in cortical cell cultures.
Sildenafil (Viagra®) down regulates cytokines and prevents demyelination in a cuprizone-induced MS mouse model.
Role of autophagy in the pathogenesis of multiple sclerosis.
Imaging multiple sclerosis and other neurodegenerative diseases.
Pages
« first
‹ previous
…
225
226
227
228
229
230
231
232
233
…
next ›
last »